1. Home
  2. Labeler Index
  3. Amneal Pharmaceuticals Of New York Llc
  4. 53746-923
  5. Product Images: Lacosamide

Product Images Lacosamide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Lacosamide NDC 53746-923 by Amneal Pharmaceuticals Of New York Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

1 - lacosamide tablets usp 50 mg 100 mg 150 mg 200 mg 1

1 - lacosamide tablets usp 50 mg 100 mg 150 mg 200 mg 1

2 - lacosamide tablets usp 50 mg 100 mg 150 mg 200 mg 2

2 - lacosamide tablets usp 50 mg 100 mg 150 mg 200 mg 2

The given text is a visual representation of Figure 1 that shows the median percent reduction in seizure frequency per 28 days from baseline to the maintenance phase by dose. The graph depicts three studies - Study 2, Study 3, and Study 4 - with different medications - Tocosamde, Lacosamide, and Placato - and their corresponding seizure reduction rates. The statistical significance of the difference compared to Placebo is denoted by an asterisk (*).*

3 - lacosamide tablets usp 50 mg 100 mg 150 mg 200 mg 3

3 - lacosamide tablets usp 50 mg 100 mg 150 mg 200 mg 3

This is a graph showing the proportion of patients who responded favorably to Lacosamide compared to a Placebo in Studies 2, 3, and 4. The Y-axis is labeled as "Responder Rate" and the X-axis shows the different doses administered. The graph indicates that patients on higher doses of Lacosamide had a higher responder rate compared to those on a placebo. The text also includes a table showing the number of patients for each treatment group.*

4 - lacosamide tablets usp 50 mg 100 mg 150 mg 200 mg 4

4 - lacosamide tablets usp 50 mg 100 mg 150 mg 200 mg 4

This is a medication guide for Lacosamide Tablets, USP, which is intended to be given to each patient. The guide provides information on dosages, administration, and potential side effects of the medication. The NDC number for this medication is 53746-923-60. The rest of the text contains some product codes and contact information, but it is difficult to understand the context.*

5 - lacosamide tablets usp 50 mg 100 mg 150 mg 200 mg 5

5 - lacosamide tablets usp 50 mg 100 mg 150 mg 200 mg 5

This appears to be a document relating to medication, particularly a packet of tablets with a dosage of 100 mg per tablet. The medication is listed as "Lacosamide" and is available only with a prescription. The document includes a barcode that may potentially lead to more information about the medication.*

6 - lacosamide tablets usp 50 mg 100 mg 150 mg 200 mg 6

6 - lacosamide tablets usp 50 mg 100 mg 150 mg 200 mg 6

This appears to be a label for medication, specifically Lacosamide Tablets. It includes the dosage, quantity (60 tablets), and a National Drug Code (NDC) number. It also includes instructions for pharmacists to dispense to each patient and a warning that it is only available by prescription (Rx Only).*

7 - lacosamide tablets usp 50 mg 100 mg 150 mg 200 mg 7

7 - lacosamide tablets usp 50 mg 100 mg 150 mg 200 mg 7

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.